New research has discovered a pathway between the heart and the brain that can cause fainting.
The discovery of this pathway could lead to new treatments for disorders that affect blood flow to the brain.
The study used genetic tools to study the vagus nerve in mice and found a group of nerve cells that connect the heart's ventricles with a small region of the brainstem.
This type of fainting, called vasovagal syncope, occurs when there is a sudden drop in heart rate and blood pressure, reducing circulation to the brain.
When these nerve cells were stimulated, the mice experienced fainting-like symptoms.
New research has shed light on the causes of fainting, a condition that affects approximately 40% of people at some point in their lives. The study focused on a type of fainting known as vasovagal syncope, which is characterized by a sudden drop in heart rate and blood pressure, leading to reduced circulation to the brain.
The research team used genetic tools to study the vagus nerve in mice, discovering a group of nerve cells that connect the heart's ventricles with a small region of the brainstem. When these nerve cells were stimulated, the mice exhibited symptoms similar to fainting.
This discovery of a pathway between the heart and the brain could potentially lead to the development of new treatments for disorders that affect blood flow to the brain. However, further research is needed to confirm these findings and explore their potential applications in human medicine.
New research has discovered a pathway between the heart and the brain that can cause fainting.
This type of fainting, called vasovagal syncope, occurs when there is a sudden drop in heart rate and blood pressure, reducing circulation to the brain.
The study used genetic tools to study the vagus nerve in mice and found a group of nerve cells that connect the heart's ventricles with a small region of the brainstem.
When these nerve cells were stimulated, the mice experienced fainting-like symptoms.
The discovery of this pathway could lead to new treatments for disorders that affect blood flow to the brain.